Innovent Biologics Statistics
Total Valuation
IVBIY has a market cap or net worth of 19.90 billion. The enterprise value is 19.04 billion.
| Market Cap | 19.90B |
| Enterprise Value | 19.04B |
Important Dates
The next estimated earnings date is Thursday, March 26, 2026.
| Earnings Date | Mar 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.74% |
| Shares Change (QoQ) | +3.84% |
| Owned by Insiders (%) | 6.40% |
| Owned by Institutions (%) | 41.28% |
| Float | 1.61B |
Valuation Ratios
The trailing PE ratio is 125.89 and the forward PE ratio is 54.22.
| PE Ratio | 125.89 |
| Forward PE | 54.22 |
| PS Ratio | 12.48 |
| PB Ratio | 9.88 |
| P/TBV Ratio | 10.94 |
| P/FCF Ratio | 98.47 |
| P/OCF Ratio | 78.48 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 107.42, with an EV/FCF ratio of 94.19.
| EV / Earnings | 120.43 |
| EV / Sales | 11.89 |
| EV / EBITDA | 107.42 |
| EV / EBIT | 157.04 |
| EV / FCF | 94.19 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.61 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 2.54 |
| Debt / FCF | 2.33 |
| Interest Coverage | 10.22 |
Financial Efficiency
Return on equity (ROE) is 8.43% and return on invested capital (ROIC) is 10.52%.
| Return on Equity (ROE) | 8.43% |
| Return on Assets (ROA) | 2.65% |
| Return on Invested Capital (ROIC) | 10.52% |
| Return on Capital Employed (ROCE) | 5.00% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | 257,593 |
| Profits Per Employee | 25,535 |
| Employee Count | 6,190 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, IVBIY has paid 11.00 million in taxes.
| Income Tax | 11.00M |
| Effective Tax Rate | 6.50% |
Stock Price Statistics
The stock price has increased by +107.57% in the last 52 weeks. The beta is 0.23, so IVBIY's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +107.57% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | 274 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IVBIY had revenue of 1.59 billion and earned 158.06 million in profits. Earnings per share was 0.09.
| Revenue | 1.59B |
| Gross Profit | 1.22B |
| Operating Income | 129.72M |
| Pretax Income | 169.06M |
| Net Income | 158.06M |
| EBITDA | 181.81M |
| EBIT | 129.72M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 1.33 billion in cash and 471.72 million in debt, with a net cash position of 859.99 million.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 471.72M |
| Net Cash | 859.99M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.01B |
| Book Value Per Share | 1.22 |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was 253.56 million and capital expenditures -51.47 million, giving a free cash flow of 202.08 million.
| Operating Cash Flow | 253.56M |
| Capital Expenditures | -51.47M |
| Free Cash Flow | 202.08M |
| FCF Per Share | n/a |
Margins
Gross margin is 76.62%, with operating and profit margins of 8.14% and 9.91%.
| Gross Margin | 76.62% |
| Operating Margin | 8.14% |
| Pretax Margin | 10.60% |
| Profit Margin | 9.91% |
| EBITDA Margin | 11.40% |
| EBIT Margin | 8.14% |
| FCF Margin | 12.67% |
Dividends & Yields
IVBIY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.74% |
| Shareholder Yield | -3.74% |
| Earnings Yield | 0.79% |
| FCF Yield | 1.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IVBIY has an Altman Z-Score of 4.57 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.57 |
| Piotroski F-Score | 8 |